Further studies implicated a (mutational) deregulation of the CCL20/CCR6 axis not only in inflammatory and infectious diseases but in disease progression across a variety of cancers, including pancreatic, colorectal, and breast cancer alongside hepatocellular carcinoma and others51. Here, CCL20 is linked to cancer.